Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥308.00 JPY
Change Today 0.00 / 0.00%
Volume 12.0K
4512 On Other Exchanges
Symbol
Exchange
Tokyo
As of 2:00 AM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - wakamoto pharm co ltd (4512)

NameBoard RelationshipsTitleAge
Nobuyuki Kamiya 10 RelationshipsPresident and Representative Director69
Arata Igarashi 10 RelationshipsManaging Director, Chief of Management Planning Office and Director56
Hideo Sugamata 10 RelationshipsSenior Managing Director, Manager of Information System Department and Director66

Board Members - wakamoto pharm co ltd (4512)

NameBoard RelationshipsPrimary CompanyAge
Nobuyuki Kamiya 10 RelationshipsWakamoto Pharmaceutical Co., Ltd.69
Hideo Sugamata 10 RelationshipsWakamoto Pharmaceutical Co., Ltd.66
Arata Igarashi 10 RelationshipsWakamoto Pharmaceutical Co., Ltd.56
Yoshihiro Horio 10 RelationshipsWakamoto Pharmaceutical Co., Ltd.63
Haruhisa Hirata 10 RelationshipsWakamoto Pharmaceutical Co., Ltd.58

Executive Committees* - wakamoto pharm co ltd (4512)

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4512:JP ¥308.00 JPY 0.00

4512 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4512.
View Industry Companies
 

Industry Analysis

4512

Industry Average

Valuation 4512 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.8x
Price/Book 0.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WAKAMOTO PHARM CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.